Literature DB >> 17169561

HMG chromosomal proteins in development and disease.

Robert Hock1, Takashi Furusawa, Tetsuya Ueda, Michael Bustin.   

Abstract

The high mobility group (HMG) proteins are a superfamily of abundant and ubiquitous nuclear proteins that bind to DNA and nucleosomes and induce structural changes in the chromatin fiber. They are important in chromatin dynamics and influence DNA processing in the context of chromatin. Results emerging from studies of human disease, genetically modified mice and cells with altered HMG expression indicate that the expression of the HMG proteins is developmentally regulated and that changes in HMG protein levels alter the cellular phenotype and can lead to developmental abnormalities and disease. Here, we focus on the biological function of HMG proteins and highlight their possible roles in cellular differentiation and in the etiology of various diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169561      PMCID: PMC2442274          DOI: 10.1016/j.tcb.2006.12.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  69 in total

1.  High-mobility group proteins 14 and 17 maintain the timing of early embryonic development in the mouse.

Authors:  O A Mohamed; M Bustin; H J Clarke
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 2.  Enhanceosomes.

Authors:  M Merika; D Thanos
Journal:  Curr Opin Genet Dev       Date:  2001-04       Impact factor: 5.578

3.  Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system.

Authors:  S Okamura; C C Ng; K Koyama; Y Takei; H Arakawa; M Monden; Y Nakamura
Journal:  Oncol Res       Date:  1999       Impact factor: 5.574

4.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

5.  In vivo modulation of Hmgic reduces obesity.

Authors:  A Anand; K Chada
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

6.  HMGN4, a newly discovered nucleosome-binding protein encoded by an intronless gene.

Authors:  Y Birger; Y Ito; K L West; D Landsman; M Bustin
Journal:  DNA Cell Biol       Date:  2001-05       Impact factor: 3.311

7.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

8.  NBP-45, a novel nucleosomal binding protein with a tissue-specific and developmentally regulated expression.

Authors:  H Shirakawa; D Landsman; Y V Postnikov; M Bustin
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

9.  A role for chromosomal protein HMGN1 in corneal maturation.

Authors:  Yehudit Birger; Janine Davis; Takashi Furusawa; Eyal Rand; Joram Piatigorsky; Michael Bustin
Journal:  Differentiation       Date:  2006-02       Impact factor: 3.880

10.  Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2.

Authors:  L Ronfani; M Ferraguti; L Croci; C E Ovitt; H R Schöler; G G Consalez; M E Bianchi
Journal:  Development       Date:  2001-04       Impact factor: 6.868

View more
  145 in total

1.  Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.

Authors:  Ning Jiang; Li-Qun Zhou; Xiao-Yu Zhang
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

2.  Efficient cell migration requires global chromatin condensation.

Authors:  Gabi Gerlitz; Michael Bustin
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 3.  Higher-order genome organization in human disease.

Authors:  Tom Misteli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

4.  Genomic profiling of HMGN1 reveals an association with chromatin at regulatory regions.

Authors:  Suresh Cuddapah; Dustin E Schones; Kairong Cui; Tae-Young Roh; Artem Barski; Gang Wei; Mark Rochman; Michael Bustin; Keji Zhao
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

5.  Transcription factors expressed in olfactory bulb local progenitor cells revealed by genome-wide transcriptome profiling.

Authors:  Gordon R O Campbell; Ariane Baudhuin; Karen Vranizan; John Ngai
Journal:  Mol Cell Neurosci       Date:  2010-12-29       Impact factor: 4.314

6.  The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.

Authors:  Xuhui Zhou; Bo Yuan; Wen Yuan; Ce Wang; Rui Gao; Junyan Wang
Journal:  Tumour Biol       Date:  2014-04-02

7.  Role of Nhp6 and Hmo1 in SWI/SNF occupancy and nucleosome landscape at gene regulatory regions.

Authors:  Matias I Hepp; Michaela Smolle; Cristian Gidi; Roberto Amigo; Nicole Valenzuela; Axel Arriagada; Alejandro Maureira; Madelaine M Gogol; Marcela Torrejón; Jerry L Workman; José L Gutiérrez
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-09       Impact factor: 4.490

Review 8.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

9.  Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells.

Authors:  Tzutzuy Ramirez; Jan Brocher; Helga Stopper; Robert Hock
Journal:  Chromosoma       Date:  2007-11-13       Impact factor: 4.316

10.  Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Authors:  Qian Li; Jiao Chen; Xiaoying Li; Bomiao Cui; Yaping Fan; Ning Geng; Qianming Chen; Ping Zhang; Yun Feng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.